July 25 (Reuters) - PuraPharm Corp Ltd 1498.HK:
TO ISSUE CONSIDERATION SHARES AS LICENCE FEE OF HK$40.2 MILLION
TO ISSUE 46.5 MILLION SUBSCRIPTION SHARES FOR GROSS PROCEEDS OF HK$20 MILLION
Further company coverage: 1498.HK
((Reuters.Briefs@thomsonreuters.com;))